A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease.
暂无分享,去创建一个
[1] J. V. Moran,et al. Characterization of LINE-1 Ribonucleoprotein Particles , 2010, PLoS genetics.
[2] N. Philip,et al. H syndrome: novel and recurrent mutations in SLC29A3 , 2010, The British journal of dermatology.
[3] V. Doviner,et al. H Syndrome: Recently Defined Genodermatosis With Distinct Histologic Features. A Morphological, Histochemical, Immunohistochemical, and Ultrastructural Study of 10 Cases , 2010, The American Journal of dermatopathology.
[4] P. Devilee,et al. Mutations in SLC29A3, Encoding an Equilibrative Nucleoside Transporter ENT3, Cause a Familial Histiocytosis Syndrome (Faisalabad Histiocytosis) and Familial Rosai-Dorfman Disease , 2010, PLoS genetics.
[5] C. Chiaverini,et al. The H syndrome: two novel mutations affecting the same amino acid residue of hENT3. , 2010, Journal of dermatological science.
[6] I. Lerer,et al. The H syndrome is caused by mutations in the nucleoside transporter hENT3. , 2008, American journal of human genetics.
[7] B. Glaser,et al. The H syndrome: a genodermatosis characterized by indurated, hyperpigmented, and hypertrichotic skin with systemic manifestations. , 2008, Journal of the American Academy of Dermatology.
[8] B. Clotet,et al. Expression and Functionality of Anti-Human Immunodeficiency Virus and Anticancer Drug Uptake Transporters in Immune Cells , 2008, Journal of Pharmacology and Experimental Therapeutics.
[9] C. Tse,et al. The role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity , 2007, Expert opinion on drug metabolism & toxicology.
[10] M. Rogers,et al. Pigmented Hypertrichotic Dermatosis and Insulin Dependent Diabetes: Manifestations of a Unique Genetic Disorder? , 2007, Pediatric dermatology.
[11] I. Hamadah,et al. Autosomal recessive plasma cell panniculitis with morphea-like clinical manifestation. , 2006, Journal of the American Academy of Dermatology.
[12] V. Broshtilova,et al. POEMS in Childhood , 2006, Pediatric dermatology.
[13] C. Macleod,et al. Interferon-gamma regulates nucleoside transport systems in macrophages through signal transduction and activator of transduction factor 1 (STAT1)-dependent and -independent signalling pathways. , 2003, The Biochemical journal.
[14] M. Comalada,et al. Macrophages require different nucleoside transport systems for proliferation and activation , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] K. Sayama,et al. Morphea Profunda , 1991, International journal of dermatology.